Product Details

VILMATA-M

A revolutionary treatment plan in Type 2 diabetes, Vilmata-M provides superior efficacy and allows more patients to reach their glycemic targets compared to continuing metformin monotherapy, without increasing the risk of hypoglycemia, without exposing to weight gain and without altering common cardiovascular risk factors (hypertension and lipid profile). Composition Each film coated tablet contains: Vildagliptin 50 mg Metformin Hydrochloride IP 1000 mg